Ingevity (NGVT)
(Real Time Quote from BATS)
$40.91 USD
-0.36 (-0.87%)
Updated Sep 20, 2024 01:54 PM ET
5-Strong Sell of 5 5
C Value D Growth C Momentum D VGM
Ingevity (NGVT) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$49.83 | $58.00 | $40.00 | 20.74% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for Ingevity comes to $49.83. The forecasts range from a low of $40.00 to a high of $58.00. The average price target represents an increase of 20.74% from the last closing price of $41.27.
Analyst Price Targets (6 )
Broker Rating
Ingevity currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 2.00 a month ago based on six recommendations.
Of the six recommendations deriving the current ABR, three are Strong Buy, representing 50% of all recommendations. A month ago, Strong Buy represented 50%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 3 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.00 | 2.00 | 2.00 | 2.33 | 2.33 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/7/2024 | CJS Securities | Jonathan Tanwanteng | Hold | Strong Buy |
8/1/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
6/11/2024 | Wells Fargo Securities | Michael J Sison | Hold | Hold |
5/8/2024 | BMO Capital Markets | John P Mcnulty | Hold | Hold |
5/7/2024 | Loop Capital Markets | Christopher Kapsch | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.00 |
ABR (Last week) | 2.00 |
# of Recs in ABR | 6 |
Average Target Price | $49.83 |
LT Growth Rate | NA |
Industry | Chemical - Specialty |
Industry Rank by ABR | 201 of 253 |
Current Quarter EPS Est: | 0.75 |
NGVT FAQs
Ingevity Corporation (NGVT) currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 6 brokerage firms.
The average price target for Ingevity Corporation (NGVT) is $49.83. The current on short-term price targets is based on 2 reports.
The forecasts for Ingevity Corporation (NGVT) range from a low of $40 to a high of $58. The average price target represents a increase of $20.74 from the last closing price of $41.27.
The current UPSIDE for Ingevity Corporation (NGVT) is 20.74%
Based on short-term price targets offered by six analysts, the average price target for Ingevity comes to $49.83. The forecasts range from a low of $40.00 to a high of $58.00. The average price target represents an increase of 20.74% from the last closing price of $41.27.